Menu Menu Menu
Nice Insight Research
Content Menu
Menu Menu Menu
To Top

Content Filter


2485 Articles available
Market Prediction

Global Autoinjectors Market to 2023 - High-Value Biologics Boosting Market Growth

PR-M11-18-NI-041
Clinical Trial Data

BD Announces Clinical Trial Data for the LUTONIX® 014 Drug-Coated Balloon Below-The-Knee IDE Trial

PR-M11-18-NI-041
Appointment

Thermo Fisher Scientific Elects New Director to Board

PR-M11-18-NI-038
Drug Discovery

Sosei Enters Collaboration to Combine Pioneering DNA Technologies With StaR® Technology to Accelerate New Drug Discovery

PR-M11-18-NI-039
Financial Results

Trovagene Announces Third Quarter 2018 Highlights and Financial Results

PR-M11-18-NI-037
Strategic Partnership

Sharp announces preferred partner agreement with Berkshire Sterile Manufacturing

PR-M11-18-NI-035
Vaccine

Enesi Pharma and Sementis Sign R&D Collaboration Focused on Needle-free Solid Dose Vaccines for Peanut Allergy and Chikungunya/Zika Infection

PR-M11-18-NI-034
Probiotics

Visiongain Report Researches Growth Opportunities Within the $59bn Global Probiotics Market

PR-M11-18-NI-033
Real World Data

Initial results from EMPRISE real-world evidence study show Jardiance® was associated with reduced risk for hospitalization for heart failure compared with DPP-4 inhibitors

PR-M11-18-NI-032
Macular Degeneration

Oxurion and Beta Therapeutics to Develop New Heparanase Inhibitors for Treatment of dry AMD

PR-M11-18-NI-031
Cannabis

Beleave Announces Seven-for-One Share Split

PR-M11-18-NI-027
Licensing Agreement

MEI Pharma and Kyowa Hakko Kirin Announce License Agreement to Develop and Commercialize ME-401 in Japan

PR-M11-18-NI-026
Oncology

Sysmex Inostics OncoBEAM™ Circulating Tumor DNA Technology Demonstrates Superior Response Prediction for Advanced Pancreatic Cancer over Standard-of-care Protein Biomarkers

PR-M11-18-NI-030
Oncology

Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Urothelial Cancer

PR-M11-18-NI-029
Cell and Gene Therapy

REGENXBIO and Abeona Therapeutics Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Disorders Using NAV AAV9 Vector

PR-M11-18-NI-028
Vaccine

Curevo Announces FDA Advancement of IND Application for CRV-101, New Shingles Vaccine Candidate

PR-M11-18-NI-024
Cannabis

The Medical Cannabis Market is Set to Expand as North American Continues to Grow

PR-M11-18-NI-025
Respiratory

Gala Enrolls First Subjects in an Early Feasibility Study of RheOx™ for Chronic Bronchitis in the United States

PR-M11-18-NI-023
Clinical Trials

Lipocine Announces Completion of Enrollment in LPCN 1144 Liver Imaging Study in Subjects At-Risk for NASH

PR-M11-18-NI-022
Stem Cells

Cellect Receives Multiple Patent Grants

PR-M11-18-NI-021
Appointment

Abzena Announces $20m Investment into Expansion of Integrated Biotherapeutics Offering (Biologics Drug Substance and ADC) and Makes Key Executive Appointment

PR-M11-18-NI-036
Licensing Agreement

Grünenthal Acquires Global Rights for Qutenza®

PR-M11-18-NI-020
FDA Approval

AcelRx Announces FDA Approval of DSUVIA™

PR-M11-18-NI-017
Dermatology

Galderma Announces FDA Approval of Restylane® Lyft For Midface Injection via Cannula

PR-M11-18-NI-019
Celiac Disease

Amgen and Provention Bio Announce Co-Development Collaboration In Celiac Disease

PR-M11-18-NI-018
New Facility

GSK Opens New Facility in Scotland

PAO-M11-18-NI-007
RNAi

Eli Lilly, Dicerna to Collaborate on RNAi Drug Development

PAO-M11-18-NI-006
Cholesterol

Third PCSK9 Inhibitor for Lowering Cholesterol Moves into Phase III Trials

PAO-M11-18-NI-005
New Partnership

Neuroscience Company Created by Bain Capital and Pfizer

PAO-M11-18-NI-004
Osteoarthritis

High-Valued Start-Up Announces Positive Results for Osteoarthritis Drug

PAO-M11-18-NI-003
Macular Degeneration

More Positive Results for Novartis Eye Drug Brolucizumab

PAO-M11-18-NI-002
FDA Approval

Genentech Receives FDA Approval for Flu Medicine

PAO-M11-18-NI-001
FDA Statement

Statement from FDA Commissioner Scott Gottlieb, M.D., on Agency's Approval of Dsuvia and the FDA's Future Consideration of New Opioids

PR-M11-18-NI-016
FDA Approval

OsteoRemedies® Announces the First FDA Cleared Dual-Antibiotic Spacer and Bone Cement with Gentamicin and Vancomycin

PR-M11-18-NI-015
Immunotherapy

I-Mab and Genexine Announce China IND Approval for Innovative Immunotherapy

PR-M11-18-NI-014
FDA Approval

Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval for SYMPAZAN™ (clobazam) Oral Film

PR-M11-18-NI-013
Financial Results

AbbVie Reports Third-Quarter 2018 Financial Results

PR-M11-18-NI-012
Market Prediction

Migraine Drugs Market Rising at Steady 3.5% During 2017 - 2025; Abortive Treatment Generates Maximum Revenue - TMR

PR-M11-18-NI-011
Genetic Testing

Invitae expands work with Alnylam Pharmaceuticals to provide access to genetic testing for primary hyperoxaluria

PR-M11-18-NI-010
Acquisition

Australis Finalizes Definitive Agreement to Acquire Rthm Technologies Inc.

PR-M11-18-NI-009
Patent

Perrigo Confirms Patent Challenge For Generic Version Of Kerydin®

PR-M11-18-NI-008
Market Intelligence

Global Specialty Pharmaceutical Partnering Terms and Agreements Report 2012-2018: Analysis by Headline Value, Upfront Payments, Milestone Payments and Royalties

PR-M11-18-NI-007
FDA Approval

Jazz Pharmaceuticals Announces FDA Approval of Xyrem® (sodium oxybate) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Pediatric Narcolepsy Patients

PR-M11-18-NI-006
New Faciliy

Thermo Fisher Scientific Opens Newly Expanded Facility in Frederick, Md.

PR-M11-18-NI-004
Analytic Testing

Thermo Fisher Scientific Announces Collaboration to Simplify Analysis of Complex Therapeutic Proteins

PR-M11-18-NI-003
Raw Materials

Green Science Alliance Co., Ltd. Has Started Production of Chitin Nanofiber, Chitosan Nanofiber

PR-M11-18-NI-002
Cannabis

Beleave Penetrates European Cannabis Market through Strategic Partnership and Adds VP International Sales

PR-M11-18-NI-001
Licensing Agreement

Rigel Pharmaceuticals Enters Collaboration and License Agreement with Kissei Pharmaceutical Co., Ltd. to Develop and Commercialize TAVALISSE™ in Japan and other Asian Countries

PR-M11-18-NI-005
FDA Statement

Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA's new consideration of labeling for sesame allergies

PR-M10-18-NI-109
Blindness

Diabetes Medication May Protect Against a Common Cause of Blindness

PR-M10-18-NI-108
Hepatitis

MYR Pharma Announces Presentation of Interim Results of MYR 203, a Phase 2 Study of Myrcludex in Combination with Pegylated Interferon in Chronic Hepatitis Delta

PR-M10-18-NI-107
Crohn's

Salix And Alfasigma Will Initiate Late-Stage Program To Study Rifaximin In Patients With Postoperative Crohn's Disease

PR-M10-18-NI-106
Diabetes

ActoBio Therapeutics™ Doses First Patient in Phase Ib/IIa Clinical Study of AG019 for the Treatment of Type 1 Diabetes

PR-M10-18-NI-105
Depression

New Data Presented at Psych Congress 2018 Sheds Light on the Significant Economic Burden of Treatment-Resistant Depression Amongst U.S. Veterans

PR-M10-18-NI-104
New Facility

Thermo Fisher Scientific Opens Newly Expanded Facility in Frederick, Md.

PR-M10-18-NI-103
Clinical Trials

RegeneRx Partner Updates on Clinical Trials

PR-M10-18-NI-102
Autism Spectrum Disorder

AMO Pharma Reports Positive Data from Investigator-Led TIDE Study of AMO-02 in Autism Spectrum Disorder

PR-M10-18-NI-101
FDA Approval

Jazz Pharmaceuticals Announces FDA Approval of Xyrem® (sodium oxybate) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Pediatric Narcolepsy Patients

PR-M10-18-NI-100
Cell and Gene Therapy

Oxford Nanopore Technologies Attracts Amgen Investment

PAO-M10-18-NI-031
Investment

Castle Creek Pharma Raises Funding to Repurpose Diacerein

PAO-M10-18-NI-030
FDA Approval

GSK’s ViiV Healthcare Seeks FDA Approval for Combination HIV Therapy

PAO-M10-18-NI-029
Oncology

Positive Results for Keytruda as a Kidney Cancer Treatment

PAO-M10-18-NI-028
Generics

FDA Looking for Way to Facilitate Simultaneous Generic Approvals

PAO-M10-18-NI-027
Oncology

New Tumor DNA Assay Will Be Used to Assess Response to a New Cancer Vaccine

PAO-M10-18-NI-026
Vaccine

Positive Opinion Announced in EU for New Dengue Fever Vaccine

PAO-M10-18-NI-025
Biosimilars

Herceptin Biosimilar Gets Positive Opinion in Europe

PAO-M10-18-NI-024
Financial Results

Perrigo To Release Third Quarter Calendar Year 2018 Financial Results On November 8, 2018

PR-M10-18-NI-097
FDA Approval

Alcami Helps Medicines Development for Global Health Secure FDA Approval of Moxidectin for River Blindness

PR-M10-18-NI-095
Influenza

Abbott Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results

PR-M10-18-NI-099
Market Prediction

Global Interventional Cardiology Market to Reach $24.96 Billion by 2027

PR-M10-18-NI-098
Novel Therapy

Novel Combination Therapy Promotes Wound Healing

PR-M10-18-NI-096
Equipment

Procuring Equipment at the Speed of Business

PAO-M10-18-CL-001
Big Data

The Evolution of Pharma Depends on Data Integration and Application

PAP-Q4-18-NI-001
Formulation

The Coming of Age of Amorphous Solid Dispersions

PAP-Q4-18-CL-004
Viral Vector Manufacturing

From Proof of Concept to Commercialization

PAP-Q4-18-CL-003
Tech Transfer

Knowledge and Experience Equal Successful Technology Transfer

PAP-Q4-18-CL-008
Equipment

A Turnkey Solution: Sourcing Equipment and Empowering Operators

PAP-Q4-18-CL-007
Oligonucleotides

Designing Effective Facilities to Meet the Growing Demand for Oligonucleotide Drugs

PAP-Q4-18-CL-002
Serialization

Regulatory Spotlight: FDA Delays Enforcement of Serialization Mandate

PAP-Q4-18-NI-011
Big Data

Big Data in Drug Development and Discovery

PAP-Q4-18-NI-006
Big Data

Big Data in Drug Manufacturing

PAP-Q4-18-NI-005
Big Data

Big Data in Drug Packaging and Distribution

PAP-Q4-18-NI-004
Clinical Trial Logistics

Preparing Clinical Trial Logistics for a No-Deal Brexit

PAP-Q4-18-CL-006
Big Data

Drug Repositioning: Facilitating Drug Repositioning with Artificial Intelligence

PAP-Q4-18-NI-009
Acquisition

The Value of Complementary Specialized Capabilities

PAP-Q4-18-CL-001
Global Network

Risk Minimization with an Integrated Global Network

PAP-Q4-18-CL-005
Design Logic

Preparative  Chromatography

PAP-Q4-18-NI-002
New Drug News

New Drug News: Regulatory Approval Brings siRNA into the Rare Disease Toolbox

PAP-Q4-18-NI-010
Investment

Foreign Investment: Chinese Capital Backs U.S. Biotech

PAP-Q4-18-NI-008
Roundtable

Q: What Innovative Technologies Had the Greatest Impact on your Company this Year? What Were the Impacts?

PAP-Q4-18-NI-007
Roundtable

Q: Looking Forward, What New Technologies/Paradigms Do You Anticipate Having the Greatest Impact Next Year (Digitalization and Industry 4.0, Serialization, etc.)?

PAP-Q4-18-NI-003
Medical Device

FDA Grants Breakthrough Device Status for MediBeacon's Transdermal GFR Measurement System

PR-M10-18-NI-094
Rheumatology

Mallinckrodt Presents Data on H.P. Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2018 ACR/ARHP Annual Meeting

PR-M10-18-NI-092
3D Bioprinting

CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants

PR-M10-18-NI-095
Licensing Agreement

REGENXBIO Announces Exclusive Worldwide License with Ultragenyx for the Treatment of CDKL5 Deficiency Disorder Using NAV Vectors

PR-M10-18-NI-093
Clinical Trials

Medicenna Presented Insights from the Phase 2b Clinical Trial of MDNA55 at the European Society for Medical Oncology 2018 Congress

PR-M10-18-NI-091
FDA Approval

FDA Approves Asthma Indication for Dupixent® (dupilumab)

PR-M10-18-NI-090
Market Prediction

Global Wound Care Market Report 2018-2024

PR-M10-18-NI-089
Patient Adherence

Medisafe Partners with Merck KGaA, Darmstadt, Germany to Improve Adherence for Patients with Cardiometabolic Disorders in Russia, Mexico and Brazil

PR-M10-18-NI-088
Investment

Qpex Biopharma Announces Closing of $33 Million Series A Financing and Launch of Company to Address Worldwide Problem of Drug-Resistant Infections

PR-M10-18-NI-087
Mergers

TaiRx, Inc. and BioHealth Innovation, Inc. Form TaiRx US to Develop and Commercialize Therapeutics and Precision Medicine Diagnostics

PR-M10-18-NI-086
Shareholder

Nxt-ID Issues Shareholder Update

PR-M10-18-NI-083
Clinical Data

Halozyme Provides Summary Results Of Data For PEGPH20 Combination Treatments Presented At ESMO 2018 Congress

PR-M10-18-NI-085
Market Prediction

Liquid Biopsy Market to Reach $3,805 Mn, Globally, by 2023 at 28.9% CAGR, Says Allied Market Research

PR-M10-18-NI-084
Breakthrough

Cellect Announces a Major Technological Breakthrough for Industrialization of Apotainer™ Stem Cell Product Line

PR-M10-18-NI-082
PR-M10-18-NI-081

BiondVax Receives €8M From the European Investment Bank (EIB) in Support of Manufacturing Facility and Ongoing Phase 3 Clinical Trial

Investment
Expansion

Quest Diagnostics Acquires Hurley Medical Center's Outreach Laboratory Services Operation in Central Michigan

PR-M10-18-NI-079
FDA Statement

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA's Comprehensive Framework to Reduce Tobacco-related Disease and Death

PR-M10-18-NI-078
Oncology

Real-world Study Shows Sequencing of Gilotrif® Followed by Osimertinib Delivered a Combined Median Time on Treatment

PR-M10-18-NI-080
Oncology

NCCN Awarded $2 Million in Research Funding from Taiho Oncology to Study Trifluridine and Tipiracil in Various Cancers

PR-M10-18-NI-077
Clinical Trials

Reistone Biopharma, a New Chinese Biotech Company Ready to Initiate its Ulcerative Colitis Phase II Clinical Trial Globally

PR-M10-18-NI-076
FDA Approval

Allergan Bags Another Body Contouring Approval

PAO-M10-18-NI-023
Pharma Marketing

Pharma’s Big Spending on TV Ads Continues in 2018

PAO-M10-18-NI-022
Patent

Humira Patent Disputes between Novartis and Abbvie Settled

PAO-M10-18-NI-021
Investment

New Fund to Focus on India

PAO-M10-18-NI-020
Approval

Xarelto Gets Approval for Additional Indication

PAO-M10-18-NI-019
FDA

Another Biosimilar Gets Nod from Independent FDA Panel

PAO-M10-18-NI-018
Influenza

Cell-Based Flu Vaccines Appear to Be More Effective than Egg-Based Strains

PAO-M10-18-NI-017
Expansion

Almac Grows in North Carolina

PAO-M10-18-NI-016
Biosimilars

Mylan and Biocon Announce Positive CHMP Opinion for Ogivri®, Biosimilar Trastuzumab

PR-M10-18-NI-071
Immunotherapy

Guardant Health Presents Data on Immunotherapy-related Biomarkers MSI and TMB in blood of advanced cancer patients

PR-M10-18-NI-075
Clinical Trials

Ward MM and Endocanna Health Announce Partnership Supporting Medicinal Cannabis Clinical Trials

PR-M10-18-NI-074
FDA Approval

Abbott's HeartMate 3 Heart Pump Now FDA Approved for Advanced Heart Failure Patients Not Eligible for a Heart Transplant

PR-M10-18-NI-072
Clinical Data

Janssen Announces New Three-Year TREMFYA® (Guselkumab) Data Demonstrates Stably Maintained Rates of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis

PR-M10-18-NI-073
Antibiotics

PolyPid Begins Phase 2 Study to Assess Safety and Efficacy of D-PLEX100 in Prevention of Abdominal Surgical Site Infections

PR-M10-18-NI-070
Dermatology

Bausch Health's Ortho Dermatologics Business To Present New Scientific Data During The Fall Clinical Dermatology Conference

PR-M10-18-NI-069
Novel Technologies

Eclipse MedCorp Acquires Transformative Technology in Regenerative Medicine

PR-M10-18-NI-067
Strategic Partnership

Cronos Group Inc. Partners with Technion Research & Development Foundation for Cannabinoid-Based Skin Care Treatments

PR-M10-18-NI-068
ADHD

Aevi Genomic Medicine Announces Completion of Enrollment for Part B of the ASCEND Trial

PR-M10-18-NI-066
Stem Cells

Cellect Announces Positive Clinical Results

PR-M10-18-NI-065
Skin Graft

Mallinckrodt's Stratatech Company Awarded $26 Million in Additional BARDA Funding for Pediatric Studies of StrataGraft® Skin Tissue in Thermal Burns

PR-M10-18-NI-063
Rheumatology

New Data Showcasing Lilly's Growing Commitment in Rheumatology to be Featured at the ACR/ARHP Annual Meeting

PR-M10-18-NI-062
Market Prediction

DMD Drugs Market Size Worth $4.11 Billion by 2023 | CAGR: 41.3%: Grand View Research, Inc.

PR-M10-18-NI-064
Biopsy

Sysmex Inostics' OncoBEAM™ Liquid Biopsy Technology Demonstrates Utility for Clinical Management of Melanoma Patients Undergoing Treatment With Targeted Therapy and Immune Checkpoint Inhibitors

PR-M10-18-NI-061
Funding

GHIT Fund Welcomes Ono Pharmaceutical Co., Ltd. as New Funding Partner

PR-M10-18-NI-059
Data

Therap's Dashboard Analytics Tool Offers Aggregate Health Care Data Insight for Improved Health Outcomes

PR-M10-18-NI-058
Announcement

United Nations chooses leading marketplace builder Arcadier to defeat non-communicable diseases around the world

PR-M10-18-NI-057
Biosimilars

Innovent Receives IND Approval to Initiate Clinical Trials in China with Sintilimab in Combination with its Biosimilar to Bevacizumab

PR-M10-18-NI-056
PR-M10-18-NI-060

New Study Examines How Pharmaceutical Industry is Embracing Digital Patient Engagement Programs

Digital Health
FDA

FDA Gives De Novo Clearance to First Over-the-Counter Hearing Aid

PAO-M10-18-NI-015
×